Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Drugs Made In America AcquisitionDMAA +0.09%14 Net Debt Paydown Yield % is 0.10% as of Jul. 26, 2026, which is 25% above its 10-year median of 0.08. GuruFocus rates DMAA with a GF Score™ of 14/100. The stock has 1 warning sign investors should review. Among 212 Diversified Financial Services companies, Drugs Made In America Acquisition ranks better than 76.42% on this metric.
Net Debt Paydown Yield % is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. It is a measure of a company's willingness and ability to reduce its debt.
As of today, Drugs Made In America Acquisition's Net Debt Paydown Yield % was 0.10%.
Drugs Made In America Acquisition (NAS:DMAA) Net Debt Paydown Yield % Explanation
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced. In other words, it is a measure of the willingness and ability of a firm's management to pay down debt. Companies that have high debt paydown yields indicate that they are more aggressive with paying down debt.
In the calculation of Net Debt Paydown Yield %, we use the reductions of TTM average total debt one-year-ago and TTM average total debt at present, divided by its Market Cap.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Drugs Made In America Acquisition Net Debt Paydown Yield % Chart
DMAA vs PLMK, TRGS, FACT: Net Debt Paydown Yield % Comparison
For the Shell Companies subindustry, Drugs Made In America Acquisition's Net Debt Paydown Yield %, along with its competitors' market caps and Net Debt Paydown Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Drugs Made In America Acquisition Net Debt Paydown Yield % vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Drugs Made In America Acquisition's Net Debt Paydown Yield % distribution charts can be found below:
* The bar in red indicates where Drugs Made In America Acquisition's Net Debt Paydown Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Net Debt Paydown Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
What does a Net Debt Paydown Yield % of 0.10% mean?
Drugs Made In America Acquisition (DMAA) has a Net Debt Paydown Yield % of 0.10% as of Jul. 26, 2026. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on Drugs Made In America Acquisition and its competitors. This is 25% above median its historical median of 0.08. Over the past decade, Drugs Made In America Acquisition's Net Debt Paydown Yield % has ranged from 0.08 to 0.10. According to the industry distribution chart, Drugs Made In America Acquisition ranks #50 out of 212 companies in the Diversified Financial Services industry, placing it in the top 23.6%.
Is Drugs Made In America Acquisition's Net Debt Paydown Yield % too high?
Drugs Made In America Acquisition's current Net Debt Paydown Yield % of 0.10% is 25% above median its 10-year median of 0.08. Over the past 10 years, this metric has ranged from a low of 0.08 to a high of 0.10. Based on the distribution chart, Drugs Made In America Acquisition ranks #50 out of 212 companies in the Diversified Financial Services industry, which is in the top quartile — a strong position relative to peers. Overall, Drugs Made In America Acquisition has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Drugs Made In America Acquisition's Net Debt Paydown Yield % compare to PLMK and TRGS?
According to the Diversified Financial Services industry distribution chart, Drugs Made In America Acquisition ranks #50 out of 212 companies for Net Debt Paydown Yield %. This places Drugs Made In America Acquisition in the top 24% of its industry — outperforming the majority of peers. Historically, Drugs Made In America Acquisition's own Net Debt Paydown Yield % has ranged from 0.08 to 0.10 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Debt Paydown Yield % for a Diversified Financial Services company?
A good Net Debt Paydown Yield % depends on the Diversified Financial Services industry context. However, Net Debt Paydown Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Debt Paydown Yield % mean?
A high Net Debt Paydown Yield % can signal that a stock is expensive relative to its fundamentals. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on Drugs Made In America Acquisition and its competitors. Drugs Made In America Acquisition's current Net Debt Paydown Yield % is 0.10%, which is 25% above median its own 10-year median of 0.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drugs Made In America Acquisition stock overvalued right now?
Drugs Made In America Acquisition (DMAA) has a current Net Debt Paydown Yield % of 0.10%. The current Net Debt Paydown Yield % is 0.10%, which is 25% above median its 10-year median of 0.08. Drugs Made In America Acquisition's overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Debt Paydown Yield % calculated?
Net Debt Paydown Yield % is calculated from a company's financial statements. For Drugs Made In America Acquisition (DMAA), the current Net Debt Paydown Yield % is 0.10% as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Drugs Made In America Acquisition Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DMAA has been successfully added to your 
